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Viabahn debranching of supraaortic branches
Abstract
Aortic arch surgery, which requires deep hypothermic circulatory arrest, has morbidity and mortality
rate up to 30% [1]. Debranching of the supraaortic vessels combined with endovascular aortic repair
(EVAR), so called hybrid procedures, have gained increasing acceptance as an alternative to open
surgery. Unfortunately, aneurysm-related remodelling of the supraaortic vessel anatomy and/or disease
extension to these vessels can make bypass surgery challenging. To minimize or avoid
manipulation-related vascular complications and reduce clamping time during debranching, we have
introduced a new non-sutured, Viabahn-based revascularisation technique of the supraaortic vessels.
This paper reports about our experience in 20 cases where Viabahn debranching was performed through
a sternotomy.
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Aortic arch surgery, which requires deep hypothermic circulatory arrest, has morbidity 
and mortality rate up to 30% [1]. Debranching of the supraaortic vessels combined with 
endovascular aortic repair (EVAR), so called hybrid procedures, have gained increasing 
acceptance as an alternative to open surgery. Unfortunately, aneurysm-related 
remodelling of the supraaortic vessel anatomy and/or disease extension to these vessels 
can make bypass surgery challenging. To minimize or avoid manipulation-related 
vascular complications and reduce clamping time during debranching, we have 
introduced a new non-sutured, Viabahn-based revascularisation technique of the 
supraaortic vessels. This paper reports about our experience in 20 cases where Viabahn 
debranching was performed through a sternotomy. 
Methods 
Patients. From May 2005 to December 2008, 20 patients have been treated with 
transsternal Viabahn debranching technique. The majority of patients were men (16). 
The mean age was 70 +/- 7 (range: 46-86). Seven patients (35%) were treated on 
nonelective basis. In 5 patients (25%) transsternal debranching of supraaortic trunks 
was perform as a redo procedure after open Ascendens and/or aortic arch surgery. The 
underlying aortic pathology was: isolated aortic arch aneurysm (10), aortic arch 
aneurysm extending to the ascending or descending aorta (6), floating thrombus within 
the aortic arch with symptomatic arm and renal arteries embolisation (1), acute aortic 
arch dissection (1) and Crawford II thoracoabdominal aneurysm extending into the aortic 
arch (2). In order to assess Viabahn debranching feasibility and measure internal 
diameter of the supraaortic trunks, CT angiography with 2 and/or 3 dimensional 
reconstructions have been performed in all patients.  
Surgery. The supraaortic vessels were approached through a partial or full length 
sternotomy. Surgical dissection was limited to the proximal stem of the supraaortic 
vessel, including when necessary the brachiocephalic artery and its branches (right 
common carotid artery and right subclavian artery). Transsection of the left innominate 
vein was required in some cases to gain access to the left subclavian artery. During 
vascular dissection, an octopus graft was prepared ex-vivo and tailored to the patient 
specific anatomy (picture 1). The octopus graft was sutured to the ascending aorta end-
to-side at first, generally just above the noncoronary sinus. Viabahn® or Hemobahn® 
stentgrafts (W.L. Gore & Associates, Flagstaff, AZ) have then been introduced and 
deployed as described below. Finally, the distal end of the octopus graft was 
anastomosed to the brachiocephalic trunk and blood flow in the right subclavian artery 
re-established. Doppler sonography was performed before the stem of the supraaortic 
vessel was interrupted by ligation or clipping. The left innominate vein was readapted 
whenever possible. Finally, drainage was introduced and the pericardium as well as the 
sternum readapted. Postoperative medication consisted in patient-adapted therapeutic 
heparinisation and aspirin 100mg/day. Once EVAR was completed, heparin was replaced 
by coumadines for a 3 months period. In 14 patients additional surgery was performed: 
renovisceral debranching (2), aortocoronary bypass surgery (4) and/or wrapping of the 
ascending aorta (8). 
Viabahn technique. (Pictures 2&3) After minimal surgical dissection of the origin of the 
target vessel, the anterior wall was punctured and a guide wire introduced about 3-4cm 
into the artery. The needle was removed and the Viabahn® introduced over-the-wire up 
to 2 cm the into the target vessel. Then, the Viabahn® was deployed and finally fully 
expanded by balloon inflation. Over- or undersizing was avoided. For debranching of 
supraaortic vessels with an internal diameter of up to 8mm, a Viabahn® was used. In 
vessels with an internal diameter of >8mm, a Hemobahn® (which covers diameters from 
9mm up to 13mm) was used. The main differences between the Viabahn® and 
Hemobahn® are the diameter of the guiding catheter (0.0035’’ for Viabahn® and 0.0025’’ 
for Hemobahn®) and the deployment direction of the device (tip to hub for the Viabahn® 
and hub to tip for the Hemobahn®). Finally, the Viabahn® or Hemobahn® was sutured to 
the feeding graft. In our latter experience (since the beginning of 2008), the Viabahn® or 
Hemobahn® was deployed within an interposition graft which has the advantage to 
render any anastomosis of the Viabahn®/Hemobahn® unnecessary. That interposition 
graft was chosen in most cases 1mm smaller in internal diameter than the 
Viabahn®/Hemobahn®. Special attention was paid to de-aerate before blood flow was re-
established. Basically, venting is performed in the same manner as with sutured 
anastomosis (inflow flushing followed by backflow flushing manoeuvre). In all cases, the 
Viabahn® or Hemobahn® was secured with two stitches on the respective artery and 
when used on the interposition graft in order to prevent slipping out. Postprocedural 
duplex sonography was performed routinely on the ICU and showed in all cases normal 
flow profiles. 
EVAR. In most cases EVAR was performed 22 days +/-21 days (range: 5 days-70 days) 
as second procedure under local anaesthesia. In eight patients with aortic dissection or 
severe access vessels or aortic kinking, antegrade EVAR was performed through the 
ascending aorta after the debranching procedure, as an all-in-one intervention. In 3 
cases, stentgrafts extended from the ascending to the infrarenal aorta. CT angiography 
and/or angiographic control of the bypass grafts was routinely performed before 
stentgraft deployment.  
Follow-up. All patients received a pre-discharge CT angiography and were controlled at 
our outpatient clinic 3 months, 6months and 12 months postoperatively and annually 
thereafter. All CT angiographies were reconstructed and reviewed by vascular surgeons 
and radiologists (picture 4). In case of a neurological event, a cranial and neck CT 
angiography was performed to detect any intracranial pathology as well as any 
underlining vascular disease.  
Results 
Overall, 56 supraaortic vessels (2.8 vessels/patient) have been debranched, 32 of which 
with Viabahn®/Hemobahn® stentgrafts (54%). Viabahn debranching was used in carotid 
artery (18), subclavian artery (13) and left vertebral artery (1). Successful Viabahn® or 
Hemobahn® deployment was achieved in all patients. In one case (3%), a Hemobahn® 
slipped out of the interposition graft before it could be fully expanded by balloon dilation. 
This was corrected by carrying out an end-to-end anastomosis between the Hemobahn 
and interposition graft. The mean ischemia time for the Viabahn®/Hemobahn® 
debranching procedure was 3 minutes (min: 1 minute, max: 9 minutes) compared to 6 
minutes (min: 5 minutes, max: 16 minutes) for a sutured anastomosis. There was no 
early occlusion of any bypass conduit (30-day patency rate 100%). Overall 30-day 
mortality rate was 15% (3/20). In emergent cases, the mortality rate was 29% (2/7) 
and in elective cases 8% (1/13). Neurological complications occurred in 3 patients (15%) 
after debranching, all of them in sutured anastomosis territories, excluding therefore a 
Viabahn®/Hemobahn® related origin. In one of the latter cases, presenting with a 
contained descending aneurysm rupture, EVAR was not performed because of poor 
neurological prognosis. There was no neurological complication during and after the EVAR 
procedures. Slight arm swelling was noted in patients where the left innominate vein was 
ligated intraoperatively or occluded postoperatively. Swelling resolved in all cases before 
discharge, without any particular treatment. One asymptomatic occlusion of a carotid 
Viabahn® was detected during the follow-up (>30 days). That patient suffered from type 
III Takayasu’s disease and had a chronic internal carotid artery occlusion already before 
the debranching procedure. One patient developed a stenosis in the aortic anastomosis of 
the feeding graft that could be successfully resolved by angioplasty and stenting through 
the right brachial artery. 
Discussion 
Hybrid procedures, where surgical supraaortic debranching is performed to allow 
stentgraft implantation into or throughout the aortic arch have shown promising results 
[2-6]. Unfortunately, debranching of the supra aortic trunks might be challenging as 
aneurismal disease often modifies profoundly the arch anatomy resulting in a cranial, 
and/or dorsal and and/or lateral positioning of the supraaortic vessels. Consecutively, the 
supraaortic vessels are located in the depth and/or laterally, beyond what is reachable 
through the standard sternotomy (picture 5). The Viabahn debranching technique, 
originally described as VORTEC (Viabahn Open Rebranching TEChnique) to revascularise 
the renal artery, allows revascularisation with only minimal vessel dissection and 
manipulation [7]. Basically, it is enough just to access or visualise the anterior vessel 
wall to be able to puncture it and to introduce the Viabahn®/Hemobahn®.  Moreover, it 
can be performed with a short ischemia time, therefore minimizing ischemia-reperfusion 
injury. In our experience of 20 supraaortic debranching procedures with 
Viabahn®/Hemobahn®, this technique proved to be technically advantageous and showed 
results similar to the VORTEC applied on the renovisceral vessels. We did not observe 
any artery dissection or vessel thrombosis and the mid-term results are promising so far, 
as there was only one Viabahn occlusion in a patient suffering from type III Takayasu’s 
disease. However, there are some limitations to the Viabahn®/Hemobahn® debranching. 
Firstly, the technique should not be applied in supra aortic vessels showing severe and 
extensive atherosclerotic lesions or a dissection of the internal carotid artery with 
extension into the carotid bifurcation, respectively. Secondly, it is probably better to use 
autologous material in mycotic aneurysms. Thirdly, durability or integrity of stentgrafts 
crossing an articulation are submitted to rotational forces and have been reported to 
have less favourable results [8-10]. However, with the transsternal Viabahn debranching 
technique, the location of the Viabahn® is purely intra-thoracic (picture 6) and the latter 
point therefore should not be an issue. Our 14 months +/- 9 months (range: 1 month-39 
months) mean midterm results seem to confirm our confidence.  
The overall 30-day mortality rate of 15% in our series of old patients (70 years in mean) 
including up to 30% of non-elective (6/20) and 35% of redo cases (7/20), compares 
favourably with other series [11,12] of hybrid procedures with conventionally sutured 
anastomosis or of conventional open repairs. The mortality rate of 8% for elective 
debranching procedures in our older population compares even more favourably with 
contemporary comparable series [2,11].  Neurological risk of the Viabahn debranching 
procedure seems to be low. Stroke occurred in 15% after the supraaortic debranching 
procedure, but could not be correlated with a Viabahn debranching territory.  
In conclusion, the Viabahn based revascularisation allows safe debranching of the 
supraaortic vessels with only short periods of ischemia, minimizing by that way cerebral 
ischemia-reperfusion injury. This technique could be advantageous in older patients and 
in anatomically challenging situations. However, our results have to be reproduced by 
others before general conclusions can be made. 
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Legend 
Picture 1. Octopus graft 
Octopus graft premounted ex-vivo. A 16mm ePTFE graft is intended to bypass the 
brachiocephalic trunk. Onto this feeding graft (FG), three grafts are sutured as 
side branches that are intended to bypass the left subclavian artery and both 
carotid arteries. The Viabahn® stentgrafts will be introduced inside these 
interposition grafts (IG1-3). Ideally, the IG will cover the Viabahn completely. 
Picture 2 (a-c). Viabahn debranching Technique 
a) The aortic end-to-side anastomosis of FG is already performed. The Viabahn® is 
introduced over a guide wire into the IG and the left subclavian artery. Blood flow 
through the native vessel is probably reduced due to the endoluminally located 
and not yet deployed Viabahn® (which has a 2.5 mm diameter when not 
deployed).  
b) The Viabahn® has been deployed into the left subclavian artery and blood flow has 
been restored through the IG after Viabahn® deployment. This is achieved within 
a couple of minutes, whereas blood flow interruption is only occurring during 
Viabahn®/Hemobahn® deployment and venting manoeuvres. Full expansion of the 
Viabahn® is achieved by balloon inflation, which is responsible for several short 
periods of blood flow interruption. 
c) The left subclavian artery and both carotid arteries have been revascularised with 
the Viabahn technique and the right subclavian artery with a conventional end-to-
side running suture on the level of the brachiocephalic trunk. The Viabahn® 
stentgrafts have been secured with some transparietal 6.0 Prolen stitches and the 
native vessels have been interrupted proximally to the anastomosis by ligation or 
clip application. 
Picture 3. Postprocedural CT angiography 
86 years old patient presenting isolated arch aneurysm (7.5cm). Viabahn 
debranching has been performed on the left subclavian and both carotid arteries. 
The feeding graft has been implanted into the ascending aorta, just above the 
sinotubular junction. A pacemaker wire has been used to mark the ostium of the 
feeding graft. The FG lands end-to-side into the brachiocephalic trunk and 
revascularises the right subclavian artery. The ascending aorta measuring initially 
5 cm in diameter has been wrapped down to 4cm with a Prolen net to allow 
landing with a 46mm device. 
 
Picture 4. Follow-up CT angiography 
 
The reconstruction shows a Viabahn® (8mm internal diameter and 5 cm in length) 
implanted a year earlier into the left common carotid artery. Note the absence of 
any stenosis at the distal end (DE) of the Viabahn® and the patent left vertebral 
artery (LVA)  
 
Picture 5. Anatomical challenge in arch aneurysm 
 
Proximal aortic arch aneurysm (6.5cm in diameter, located ventrally [/]) 6 
years after ascending graft replacement (*) for acute type A dissection. Note the 
unfavourable depth and lateral location of the left subclavian artery (LSA). 
Brachiocephalic trunk (BCT) and left carotid artery (LCA). 
 
Picture 6. Postprocedural CT angiography 
 
Note the intrathoracic landing of the Viabahn® implanted into the left common 
carotid artery (red arrow) 
Picture 1 
 

















• Debranching the supra aortic vessels into the ascending aorta is performed to allow 
endovascular aneurysm repair (EVAR) with commercially available tubular stentgrafts 
implanted into or over the arch. 
• To facilitate the debranching procedure of the supra aortic vessels, a new nonsutured 
anastomosis technique, based on the Viabahn® stentgraft (W.L. Gore & Associates, 
Flagstaff, AZ), is introduced. 
• The technical success rate of the sutured (n=24) and non-sutured (n=32) supraaortic 
debranching procedures was 100%. 
• The mean ischemia time for the Viabahn® supraaortic debranching procedure was 
significantly shorter compared to sutured anastomosis (3 minutes versus 6 minutes). 
• Overall short-term (30 days) patency of supraaortic debranching was 100% and mid-
term (14 months) patency rate of the Viabahn® debranching was 97%. 
• Overall short-term mortality rate was 15% and in elective patients 8%. 
• Neurological complication rate was 15%. However, none of the three strokes occurred 
in territories of Viabahn® debranching. 
• The non-sutured Viabahn debranching technique seems to be a safe and valuable 
alternative to standard bypass for supraaortic debranching and should be considered in 
the high-risk patient and/or in patients with challenging supra aortic anatomy. 
 
 
